Matthieu Mahévas
Impact in
- Hematology top 0.5%
- Platelet Disorders and Treatments
- Blood groups and transfusion
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 64
- Platelet Disorders and Treatments 58
- Blood groups and transfusion 41
- Genetics 21
- Chronic Lymphocytic Leukemia Research 16
- Blood disorders and treatments 7
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Co-authors
- Bertrand Godeau (45 shared papers)Marc Michel (42 shared papers)Sylvain Audia (14 shared papers)Bernard Bonnotte (6 shared papers)Maxime Samson (1 shared paper)Philippe Bierling (20 shared papers)Nicolas Limal (18 shared papers)Mehdi Khellaf (10 shared papers)
- Journals
- Blood (17 papers)British Journal of Haematology (14 papers)American Journal of Hematology (11 papers)Autoimmunity Reviews (3 papers)Haematologica (3 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Matthieu Mahévas
85 papers receiving 2.6k citations
Matthieu Mahévas's Hit Papers
Peers
Comparison fields: 5 of 106
- Hematology 1.7k
- Genetics 431
- Pathology and Forensic Medicine 381
- Nephrology 139
- Immunology 331
Countries citing papers authored by Matthieu Mahévas
This map shows the geographic impact of Matthieu Mahévas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthieu Mahévas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthieu Mahévas more than expected).
Fields of papers citing papers by Matthieu Mahévas
This network shows the impact of papers produced by Matthieu Mahévas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthieu Mahévas. The network helps show where Matthieu Mahévas may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthieu Mahévas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 285 | |
| 2 | 2012 | 280 | |
| 3 | 2020 | 216 | |
| 4 | Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database Hit paper breakdown → | 2022 | 127 |
| 5 | 2014 | 118 | |
| 6 | 2014 | 115 | |
| 7 | 2021 | 98 | |
| 8 | 2016 | 72 | |
| 9 | 2020 | 72 | |
| 10 | 2017 | 71 | |
| 11 | 2019 | 67 | |
| 12 | 2014 | 64 | |
| 13 | 2015 | 61 | |
| 14 | 2012 | 58 | |
| 15 | 2013 | 52 | |
| 16 | 2014 | 50 | |
| 17 | 2013 | 49 | |
| 18 | 2015 | 48 | |
| 19 | 2018 | 48 | |
| 20 | 2013 | 40 |
About Matthieu Mahévas
Matthieu Mahévas is a scholar working on Hematology, Genetics, Nephrology, Pathology and Forensic Medicine and Rheumatology, having authored 91 papers that have together received 2.6k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (58 papers), Blood groups and transfusion (41 papers), Autoimmune Bullous Skin Diseases (16 papers), Chronic Lymphocytic Leukemia Research (16 papers), Renal Diseases and Glomerulopathies (13 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Blood disorders and treatments (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). The work is most often cited by research in Hematology (1.7k citations), Genetics (431 citations), Pathology and Forensic Medicine (381 citations), Nephrology (139 citations) and Immunology (331 citations). Matthieu Mahévas has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Bertrand Godeau, Marc Michel, Sylvain Audia, Bernard Bonnotte, Maxime Samson, Philippe Bierling, Nicolas Limal, Mehdi Khellaf, Laetitia Languille and Françoise Roudot‐Thoraval. Their work appears in journals such as Blood, British Journal of Haematology, American Journal of Hematology, Autoimmunity Reviews and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.